Search
for
Sort by
Research 61–90 of 1000+
- Main Plenary Sessions: Summaries of Papers
- Cytostatics and immunosuppressive drugs
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
- CD44 signaling in skin wound healing and regeneration
- Dermal TRPV1 innervations engage a macrophage- and fibroblast-containing pathway to activate hair growth in mice
- Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation
- Update on the dermatologic use of systemic glucocorticosteroids
- Psychoactive drugs and skin
- Teriflunomide in multiple sclerosis: an update
- Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
- 公表学術論文等リスト 2018
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- The skin and obesity
- Severe cardiac conduction abnormalities associated with atypical toxic shock syndrome
- Cutaneous Markers of Disorders Affecting Adult Horses
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- New-onset systemic lupus erythematosus during pregnancy: A challenge in diagnosis
- Clinicopathologic lessons in distinguishing cicatricial alopecia: 7 Cases of lichen planopilaris misdiagnosed as discoid lupus
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Prevalence and treatment approach of canine Demodicosis
- Severe Acute Respiratory Syndrome Among Children
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Case report: pemphigus vulgaris in an adolescent
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Kawasaki disease: an update
- Differential impact of environmental factors on systemic and localized autoimmunity
- Severe cutaneous adverse reactions to drugs